Update to transparency law takes effect in Spain

30 January 2017

As of now, collaborations between healthcare professionals and pharma in Spain are to be published individually, following an update to Code of Good Practice on the pharmaceutical industry.

In April 2016, Spanish trade group Farmaindustria gave the green light to the amendment of the code by which all companies adhering to it will inform healthcare professionals that transfers of value made from January 1, 2017 (to be disclosed in 2018) derived from their collaboration as far as education, scientific-professional meetings and services provision, will be disclosed in an individual manner.

"It will be positive for the health sector, for its professionals and, above all, for patients and society in general"

This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Try before you buy

Free

7 day trial access

Take a Free Trial

All the news that moves the needle in pharma and biotech
Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
Receive The Pharma Letter daily news bulletin, free forever.

Become a subscriber

£820

Or £77 per month

Subscribe Now

Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
Daily roundup of key events in pharma and biotech.
Monthly in-depth briefings on Boardroom appointments and M&A news.
Choose from a cost-effective annual package or a flexible monthly subscription

The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK